Hong Kong as Your Gateway to Asia - Accessing Export Markets and Unlocking Investment
Webinar Event
Hong Kong as your Gateway to Asia - Accessing export markets and unlocking investment
Presented in partnership with Austrade, MTAA invites you to join us as we explore why Hong Kong is rapidly becoming a key gateway for MedTech, healthcare innovation and expansion. This session will provide an up‑to‑date overview of market opportunities, regulatory developments and government support programs designed to accelerate growth for MedTech companies.
During this session, our speakers will cover:
Hong Kong Healthcare System & Market Landscape
A snapshot of Hong Kong’s current healthcare environment and emerging opportunities for MedTech and health technology companies.
Medical Device, Drug & Therapy Registration Pathways
An overview of Hong Kong’s regulatory mechanisms—plus insights into the newly established Hong Kong Centre for Medical Products Regulation and what it means for market access.
Hong Kong’s Role in the Greater Bay Area (GBA)
How policy developments are strengthening Hong Kong’s connection to the GBA and creating new opportunities for cross‑border collaboration.
Government Support for Life & Health Technology
Learn about initiatives designed to foster innovation, including:
- The new Hong Kong Science Park
- New clinical trial centre
- Funding programs and incentives
Investment Landscape
A brief look at current healthcare investment trends and opportunities in Hong Kong.
Success Stories – Why Hong Kong?
Hear from companies such as Harrison.ai (or other partners) on why Hong Kong was the right choice and the impact it has had on their growth.
Asia Summit on Global Health (ASGH)
A preview of the upcoming ASGH program taking place in May. Find out more here.
Who Should Attend
This webinar is ideal for MedTech leaders, innovators, investors and organisations looking to understand the unique advantages Hong Kong offers as a launchpad into Asia. Specifically;
- Australian MedTech manufacturing companies
- Digital health companies
- Organisations seeking to understand the commercial potential of the Hong Kong market
- Teams wanting clarity on market entry, regulatory requirements, and growth pathways in Hong Kong and the GBA
If your business is exploring expansion in Asia or wants to better understand Hong Kong’s role as a MedTech gateway, this session is for you.
About MedTech Compass
MedTech Compass is MTAA's membership initiative helping start-ups and scale-ups navigate the path to growth. From building capability, mentorship, toolkits to investor readiness and global market connections, we’re here to guide your MedTech journey every step of the way. Find out more & join now: https://www.medtechcompass.org.au/
Not an MTAA Member?
Be part of the industry association championing MedTech. Contact us to learn more!
Please note: This webinar will be recorded and may be shared in the future at the discretion of the MTAA and that by registering for this event you agree to MTAA's Terms and Conditions and MTAA's Privacy Policy.
Contact Information
Additional Information
Speakers
Liu Bing has been the Deputy Consul-General (Commercial) and Senior Trade and Investment Commissioner at the Australian Consulate-General in Hong Kong and Macau since August 2024.
Bing has had a distinguished career with Austrade, commencing her journey in 2001. She brings a wealth of experience in trade and investment, particularly within the China market.
Before her current role, she served as the Deputy Consul-General and Senior Trade and Investment Commissioner in Shanghai, where she led the Austrade East China network, facilitating business opportunities for Australian businesses in trade, education, and investment. Bing held several senior executive positions, including Asia Lead, Acting Executive Director for the Asia Market, Acting General Manager Asia and Senior China Adviser. In these leadership roles, she contributed to strategic initiatives and market entry for Australian businesses while overseeing Austrade’s initiatives across Asia.
Bing's earlier experience includes positions at the Australian Consulate in Guangzhou and the Australian Embassy in Beijing from 2004 to 2012, further solidifying her expertise in navigating the complexities of the Chinese market.
Her diverse experience enables her to effectively strengthen ties between Australia and the Asian markets.
She holds a Bachelor of Medicine from China and a Bachelor of Nursing from Australia.
Harrison.ai is a global healthcare technology company that develops clinician-led, AI-powered medical diagnostic support and workflow solutions, which support radiologists and pathologist to make faster and accurate diagnoses and improving patient outcomes. Its AI solution has been adopted in 1000+ sites across four continents including Public Accident & Emergency departments and Gleneagles Hospital in Hong Kong.
Being Regional Director - Asia in Harrison.ai, Teodor is a commercial leader in fast-growing health tech. He drives growth and improves access to care, leads diverse teams and builds strong healthcare partnerships. He has worked across Asia, the Middle East and Europe. His experience includes medical imaging, data interoperability, digital health products, hospital operations and patient experience.
Dr. Maggie Lo is the Chief Manager (Life and Health Technology) at the Office for Attracting Strategic Enterprises (OASES) since December 2022. OASES is the government department responsible for attracting both mainland and international innovation and technology companies to establish or expand their operations in Hong Kong.
Before joining the government, Dr. Lo held various roles in universities and health authorities in Hong Kong, the UK, and Canada. Her experience includes clinical research as well as trade and investment promotion, during which she supported numerous companies in establishing or expanding their presence in Hong Kong.
Dr. Lo holds a PhD in Psychiatry from the University of Liverpool.
Moderator
As Innovation, Growth Lead at the Medical Technology Association of Australia (MTAA), I work at the intersection of industry, capital and policy to strengthen and scale Australia’s Medtech ecosystem. My focus is on unlocking growth pathways for medical technology companies, from early-stage innovation through to global expansion, and ensuring the right investment, regulatory and commercial settings exist for success. Medtech is not just my sector - it’s my expertise. I bring deep knowledge across innovation pipelines, capital strategy, reimbursement, regulation and commercialisation. I’m passionate about translating complex industry issues into clear, strategic conversations that drive outcomes for patients, companies and the broader healthcare system.
